Successful treatment of MAP2K1 mutant stage IV-M1d melanoma with trametinib plus low-dose dabrafenib: a case report.

Saved in:

Bibliographic Details
Title:	Successful treatment of MAP2K1 mutant stage IV-M1d melanoma with trametinib plus low-dose dabrafenib: a case report.
Authors:	Dirven I; Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel) and Vrije Universiteit Brussel (VUB), Brussels, Belgium., Calliauw E; Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel) and Vrije Universiteit Brussel (VUB), Brussels, Belgium., Awada G; Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel) and Vrije Universiteit Brussel (VUB), Brussels, Belgium., Vounckx M; Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel) and Vrije Universiteit Brussel (VUB), Brussels, Belgium., Kessels JI; Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel) and Vrije Universiteit Brussel (VUB), Brussels, Belgium., Neyns B; Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel) and Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Source:	Frontiers in medicine [Front Med (Lausanne)] 2024 Sep 09; Vol. 11, pp. 1436774. Date of Electronic Publication: 2024 Sep 09 (Print Publication: 2024).
Publication Type:	Case Reports; Journal Article
Journal Info:	Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2296-858X
DOI:	10.3389/fmed.2024.1436774